Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma

PURPOSE: Therapeutic advances for diffuse large B-cell lymphoma (DLBCL) have led to an increasing number of survivors. Both DLBCL and its treatments perturb the immune system, yet little is known about immune health during extended survivorship. METHODS: In this retrospective cohort study, we compar...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Shree, Tanaya, Li, Qian, Glaser, Sally L., Brunson, Ann, Maecker, Holden T., Haile, Robert W., Levy, Ronald, Keegan, Theresa H. M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2020
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238489/
https://ncbi.nlm.nih.gov/pubmed/32083991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01937
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi